Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Boggio

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Plos One|March 20, 2018
Quantifying autophagy using novel LC3B and p62 TR-FRET assaysAlberto Bresciani, Maria Carolina Spiezia, Roberto Boggio, et al.
European Journal of Medicinal Chemistry|December 3, 2015
Synthesis, biological characterization and molecular modeling insights of spirochromanes as potent HDAC inhibitorsFlorian Thaler, Loris Moretti, Raffaella Amici, et al.
Chemmedchem|June 24, 2010
Synthesis and biological characterization of amidopropenyl hydroxamates as HDAC inhibitorsFlorian Thaler, Mario Varasi, Andrea Colombo, et al.
Journal of Medicinal Chemistry|March 23, 2011
Discovery, synthesis, and pharmacological evaluation of spiropiperidine hydroxamic acid based derivatives as structurally novel histone deacetylase (HDAC) inhibitorsMario Varasi, Florian Thaler, Agnese Abate, et al.
Chemmedchem|March 26, 2013
tert-Butylcarbamate-containing histone deacetylase inhibitors: apoptosis induction, cytodifferentiation, and antiproliferative activities in cancer cellsSergio Valente, Daniela Trisciuoglio, Maria Tardugno, et al.
European Journal of Medicinal Chemistry|May 7, 2013
Synthesis and biological characterization of spiro[2H-(1,3)-benzoxazine-2,4'-piperidine] based histone deacetylase inhibitorsFlorian Thaler, Mario Varasi, Agnese Abate, et al.
Chemmedchem|February 23, 2012
Spiro[chromane-2,4'-piperidine]-based histone deacetylase inhibitors with improved in vivo activityFlorian Thaler, Mario Varasi, Giacomo Carenzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2017
Phosphorylation of huntingtin at residue T3 is decreased in Huntington's disease and modulates mutant huntingtin protein conformationCristina Cariulo, Lucia Azzollini, Margherita Verani, et al.
Chemmedchem|April 23, 2014
Chiral resolution and pharmacological characterization of the enantiomers of the Hsp90 inhibitor 2-amino-7-[4-fluoro-2-(3-pyridyl)phenyl]-4-methyl-7,8-dihydro-6H-quinazolin-5-one oximeRaffaella Amici, Chiara Bigogno, Roberto Boggio, et al.
Plos One|December 3, 2014
Polyglutamine- and temperature-dependent conformational rigidity in mutant huntingtin revealed by immunoassays and circular dichroism spectroscopyValentina Fodale, Natalie C Kegulian, Margherita Verani, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Plos One|March 20, 2018
Quantifying autophagy using novel LC3B and p62 TR-FRET assaysAlberto Bresciani, Maria Carolina Spiezia, Roberto Boggio, et al.
European Journal of Medicinal Chemistry|December 3, 2015
Synthesis, biological characterization and molecular modeling insights of spirochromanes as potent HDAC inhibitorsFlorian Thaler, Loris Moretti, Raffaella Amici, et al.
Chemmedchem|June 24, 2010
Synthesis and biological characterization of amidopropenyl hydroxamates as HDAC inhibitorsFlorian Thaler, Mario Varasi, Andrea Colombo, et al.
Journal of Medicinal Chemistry|March 23, 2011
Discovery, synthesis, and pharmacological evaluation of spiropiperidine hydroxamic acid based derivatives as structurally novel histone deacetylase (HDAC) inhibitorsMario Varasi, Florian Thaler, Agnese Abate, et al.
Chemmedchem|March 26, 2013
tert-Butylcarbamate-containing histone deacetylase inhibitors: apoptosis induction, cytodifferentiation, and antiproliferative activities in cancer cellsSergio Valente, Daniela Trisciuoglio, Maria Tardugno, et al.
European Journal of Medicinal Chemistry|May 7, 2013
Synthesis and biological characterization of spiro[2H-(1,3)-benzoxazine-2,4'-piperidine] based histone deacetylase inhibitorsFlorian Thaler, Mario Varasi, Agnese Abate, et al.
Chemmedchem|February 23, 2012
Spiro[chromane-2,4'-piperidine]-based histone deacetylase inhibitors with improved in vivo activityFlorian Thaler, Mario Varasi, Giacomo Carenzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2017
Phosphorylation of huntingtin at residue T3 is decreased in Huntington's disease and modulates mutant huntingtin protein conformationCristina Cariulo, Lucia Azzollini, Margherita Verani, et al.
Chemmedchem|April 23, 2014
Chiral resolution and pharmacological characterization of the enantiomers of the Hsp90 inhibitor 2-amino-7-[4-fluoro-2-(3-pyridyl)phenyl]-4-methyl-7,8-dihydro-6H-quinazolin-5-one oximeRaffaella Amici, Chiara Bigogno, Roberto Boggio, et al.
Plos One|December 3, 2014
Polyglutamine- and temperature-dependent conformational rigidity in mutant huntingtin revealed by immunoassays and circular dichroism spectroscopyValentina Fodale, Natalie C Kegulian, Margherita Verani, et al.
Pageof 3